118 Chapter 3 REFERENCES 1. Farrugia A, Scaramuccia D. The dynamics of contract plasma fractionation. Biologicals. 2017;46:159-167. 2. Lunemann JD, Quast I, Dalakas MC. Efficacy of intravenous immunoglobulin in neurological diseases. Neurotherapeutics. 2016;13(1): 34-46. 3. Meyer A, Scire CA, Talarico R, et al. Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines. RMD Open. 2018;4(Suppl 1):e000784. 4. Na IK, Buckland M, Agostini C, et al. Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies. Eur J Haematol. 2019;102:447-456. 5. Vultaggio A, Azzari C, Milito C, et al. Subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter study. Clin Drug Investig. 2015;35(3):179-185. 6. Blau IW, Conlon N, Petermann R, Nikolov N, Plesner T. Facilitated subcutaneous immunoglobulin administration (fSCIg): a new treatment option for patients with secondary immune deficiencies. Expert Rev Clin Immunol. 2016;12(7):705-711. 7. Wasserman RL. Clinical practice experience with HyQvia in adults using alternative dosing regimens and pediatric patients: a retrospec- tive study. Adv Ther. 2020;37(4):1536-1549. 8. Health Canada. Protecting Access to Immune Globulins for Canadians: Final Report of the Expert Panel on Immune Globulin Product Supply and Related Impacts in Canada. 2018. Accessed August 23, 2018. https://donationethics.com/static/IGReport.pdf 9. Markets and Markets. Plasma Fractionation Market–Global Forecast to 2021. 2016. 10. Hartmann J. Google trends as an early indicator for shortages of intravenous immunoglobulin (IVIG). Transfusion. 2020;60(8):1656- 1657. 11. Ziesenitz VC, Mazer-Amirshahi M, Zocchi MS, Fox ER, May LS. U.S. Vaccine and immune globulin product shortages, 2001-15. Am J Health Syst Pharm. 2017;74(22):1879-1886. 12. Hotchko M. Overview of current plasma protein industry trends – IG & Plasma Collection. PLUS Meeting; Presented on January 23, 2020, 2020. 13. The Marketing Research Bureau I. The Worldwide Plasma Proteins Market – 2018. Marketing Research Bureau; 2020. 14. Langi Sasongko P, Rolink M, Van den Hurk K, van Kraaij M, Janssen M. Past, present, and future: a qualitative and literature study identifying historical trends, drivers, and transformational fac- tors for the future demand of blood supply in The Netherlands. Transfusion. 2019;59(11):3413-3423. 15. Amer M, Daim TU, Jetter A. A review of scenario planning. Futures. 2013;46:23-40.
RkJQdWJsaXNoZXIy MTk4NDMw